Skip to main content
Title
Assistant Professor
Office Location
164 Frelinghuysen Road, Piscataway, NJ 08854
Phone Number
(848) 445-4095
Email
christina.glytsou@rutgers.edu
Website
ORCID
LinkedIn
Twitter

Christina Glytsou

Principal Investigator

Dr. Christina Glytsou holds a joint appointment as an Assistant Professor in the Department of Chemical Biology at the Ernest Mario School of Pharmacy of Rutgers University and the Department of Pediatrics at Rutgers Robert Wood Johnson Medical School since January 2023. She is a member of Cancer Metabolism & Immunology and the Cancer Pharmacology Programs, at the Cancer Institute of New Jersey.

Dr. Glytsou studied Biology and Molecular Medicine at the National & Kapodistrian University of Athens in Greece. Throughout her undergraduate studies, she explored the complexity of cancer pathogenesis through studies on how cytogenetic aberrations and genomic instability affect tumor progression. Then, she moved to Italy to pursue her PhD in the University of Padua – one of the oldest Universities in the world. During her graduate studies under the mentorship of Dr. Luca Scorrano, she investigated the morphology and functions of the subcellular organelles called mitochondria during programmed cell death. Fascinated by the role of mitochondrial dynamics in physiology, Dr. Glytsou sought to use her expertise in mitochondrial biology to readdress molecular pathways in cancer pathogenesis amenable to therapeutic targeting. For her postdoctoral training, she moved to New York and New York University School of Medicine, in the laboratory of Dr. Iannis Aifantis. There her research dissected liabilities and synergies of apoptosis-inducing targeted therapies in acute myeloid leukemia. Dr. Glytsou’s studies uncovered for the first time mitochondrial structural adaptations as a mechanism of drug resistance in leukemia.

Dr. Glytsou’s laboratory aims to address fundamental questions unravelling the role of mitochondrial biology in blood malignancies progression and upon the gain of drug resistance. Ultimately the research goal of Dr. Glytsou interdisciplinary program is to leverage basic cancer cell knowledge to rationally develop effective intervention strategies and improve the patients’ outcome.

Awards & Distinctions